Veru (VERU)
(Delayed Data from NSDQ)
$1.47 USD
+0.14 (10.53%)
Updated May 14, 2024 04:00 PM ET
After-Market: $1.47 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth B Momentum F VGM
Brokerage Reports
Veru Inc. [VERU]
Reports for Purchase
Showing records 81 - 92 ( 92 total )
Company: Veru Inc.
Industry: Cosmetics
Preclinical Data in Four Types of Cancers to Be Presented at ASCO 2018; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Veru Inc.
Industry: Cosmetics
FY2018 2Q Financial Results Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Veru Inc.
Industry: Cosmetics
Tamsulosin DRS NDA Filing Fee Waived; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Veru Inc.
Industry: Cosmetics
$10M Non-Dilutive Financing Secured; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Veru Inc.
Industry: Cosmetics
FY2018 1Q Financial Results Reported; NDA Filing On Track; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Veru Inc.
Industry: Cosmetics
Large Public Sector FC2 Orders Expected in 2018; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Veru Inc.
Industry: Cosmetics
FY2017 4Q and Full-Year Financial Results; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Veru Inc.
Industry: Cosmetics
Delayed Release Solifenacin for Overactive Bladder In-licensed; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Veru Inc.
Industry: Cosmetics
Tamsulosin DRS Demonstrates AUC Equivalence; NDA Filing in 1H 2018; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Veru Inc.
Industry: Cosmetics
Preboost Co-Promotion Agreement and FC2 Telemedicine Access; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Veru Inc.
Industry: Cosmetics
FY2017 3Q Financial Results Reported; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Company: Veru Inc.
Industry: Cosmetics
FY2017 3Q Financial Results Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.